{1-[(thiophen-3-yl)methyl]piperidin-4-yl}methanol, 95.0%, 500mg

ethyl 6-Bromo-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxylate, 96%, 1g

1-[(6-Chloropyridin-3-yl)methoxy]pyrrolidine-2,5-dione, 95.0%, 5g

Dolasetron>98.0%(HPLC)50mg

6-Aminopyridin-3-ol hydrobromide, 95.0%, 5g

Spiro[2-benzofuran-3,4'-piperidine]-1-one;hydrochloride, 97%, 100mg

(S)-2,6-Diaminohexanoic acid compound with (S)-2-aminosuccinic acid (1:1), 95.0%, 5g

4-Chloro-6-(4-chlorophenyl)-2-(pyridin-3-yl)pyrimidine, 98%, 250mg

Methyl 2,5-bis(trifluoroethoxy)benzoate, 95.0%, 1g

[(1S)-1-carboxy-2,2-dimethylpropyl](diazyn-1-ium-1-yl)azanide, ��97.0%, 2.5g

6-Pyrrolidin-1-yl-nicotinic acid, 95.0%, 250mg

ethyl 7-amino[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate, 25g

4-amino-6-fluoro-3-quinolinecarboxylic acid dihydrate, 95.0%, 5g